Bruton's tyrosine kinase (abbreviated Btk or BTK), also known as tyrosine-protein kinase BTK, is a tyrosine kinase that is encoded by the BTK gene in humans...
22 KB (2,389 words) - 06:43, 22 April 2024
name: "Bruton-type agammaglobulinemia". The gene associated with this defect is also named after him: Btk, abbreviation for Bruton's tyrosine kinase. He...
8 KB (994 words) - 15:07, 18 April 2024
been identified that are regulated by PtdIns(3,4,5)P3, including Bruton's tyrosine kinase (BTK), General Receptor for Phosphoinositides-1 (GRP1), and the...
32 KB (3,463 words) - 17:34, 20 November 2023
X-linked agammaglobulinemia (redirect from Bruton's Agammaglobulinemia)
develop serious and even fatal infections. A mutation occurs at the Bruton's tyrosine kinase (Btk) gene that leads to a severe block in B cell development (at...
15 KB (1,814 words) - 16:26, 20 February 2023
Tyrosine-protein kinase SYK, also known as spleen tyrosine kinase, is an enzyme which in humans is encoded by the SYK gene. SYK, along with ZAP70, is...
18 KB (2,083 words) - 06:18, 25 December 2023
Nemtabrutinib (category Tyrosine kinase inhibitors)
formerly ARQ 531) is a small molecule drug that works as a reversible Bruton's tyrosine kinase (BTK) inhibitor; unlike other BTK inhibitors it also works against...
7 KB (501 words) - 19:50, 24 April 2024
ATC code L01 Antineoplastic agents is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes...
12 KB (877 words) - 15:36, 25 January 2024
including tislelizumab, a checkpoint inhibitor, and zanubrutinib, a Bruton's tyrosine kinase inhibitor. In addition to clinical research, BeiGene's early business...
25 KB (2,299 words) - 17:57, 21 May 2024
Zanubrutinib (category Kinase inhibitors)
chronic lymphocytic leukemia (CLL). Zanubrutinib is classified as a Bruton's tyrosine kinase (BTK) inhibitor. It is given by mouth. It was approved for medical...
23 KB (1,765 words) - 02:36, 28 April 2024
standard of care, but numerous clinical trials are ongoing. Two Bruton tyrosine kinase inhibitors (BTKi), one In November 2013, ibrutinib (brand name Imbruvica...
41 KB (4,549 words) - 08:59, 25 January 2024